Access Statistics for Jo Seldeslachts

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on Gas Hub Prices 0 0 0 46 1 2 6 84
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 23 2 2 5 45
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 1 21 1 1 2 37
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 22 2 3 9 45
A retrospective evaluation of the GDF/Suez merger: Effects on gas hub prices 0 0 0 55 4 5 7 69
Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development 1 1 2 12 5 6 14 25
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 1 1 3 3 8 10
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 3 16 2 3 8 19
Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development 1 1 27 27 4 5 41 41
Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development 0 1 12 12 4 6 10 10
Collusion through Joint R&D: An Empirical Assessment 0 1 2 64 2 4 6 118
Collusion through Joint R&D: An Empirical Assessment 0 0 0 78 4 5 7 191
Collusion through joint R&D: An empirical assessment 0 0 0 167 1 3 4 220
Common Ownership Patterns in the European Banking Sector – The Impact of the Financial Crisis 0 0 1 8 2 2 4 13
Common Ownership and Market Entry: Evidence from Pharmaceutical Industry 0 0 0 61 3 5 8 260
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 2 55 5 7 11 95
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 60 3 7 14 235
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 1 15 0 3 4 42
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 1 22 4 5 7 69
Common Ownership: Europe vs. the US 0 0 1 6 2 5 7 14
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 17 4 7 8 93
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 98 2 4 8 117
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 13 1 2 5 35
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 15 1 4 5 25
Common ownership: Europe vs. the US 0 0 0 5 3 3 7 22
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 34 0 1 1 63
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 44 1 2 3 69
Effective European antitrust: Does EC merger policy generate deterrence? 0 0 0 1 1 2 4 41
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 57 0 1 1 164
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 45 4 10 13 227
Interactions Between Product and Labour Market Reforms 0 0 0 283 1 5 8 1,085
Merger Clusters during Economic Booms 0 0 1 100 1 2 6 393
Merger Failures 0 0 1 450 2 7 9 1,333
Merger failures 0 0 1 229 4 5 12 583
Mergers, Investment Decisions and Internal Organisation 0 0 0 86 1 3 4 447
Mergers, Investment Decisions and Internal Organisation 0 0 0 343 2 4 5 1,290
Mergers, Investment Decisions and Internal Organisation 0 0 0 192 1 2 3 473
Mergers, Investment Decisions and Internal Organisation 0 0 1 6 2 3 6 76
On The Stability of Research Joint Ventures: Implications for Collusion 0 0 0 68 0 1 1 224
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 71 0 4 4 267
Ownership Diversification and Product Market Pricing Incentives 0 0 0 17 6 14 21 60
Ownership Diversification and Product Market Pricing Incentives 0 0 0 1 1 1 4 7
Ownership diversification and product market pricing Incentives 0 0 0 2 2 6 14 20
R&D Spillovers through RJV Cooperation 0 0 0 3 0 3 6 29
R&D Spillovers through RJV Cooperation 0 0 0 9 0 2 3 23
R&D Spillovers through RJV Cooperation 0 0 0 5 0 2 5 17
R&D Spillovers throught RJV Cooperation 0 0 0 18 3 6 9 55
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 51 2 3 4 203
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 69 2 3 4 280
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 48 0 1 2 195
Screening and Merger Activity 0 0 0 91 1 2 5 360
The Contingent Effect of Alliance Design on Alliance Dynamics and Performance: An Experimental Study 0 0 0 30 2 3 7 57
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 15 2 4 8 99
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 32 0 1 1 141
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 96 1 3 4 315
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 108 0 1 1 375
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 1 136 2 5 8 136
US and EU Secure Vaccine Production on Home Soil 0 0 0 13 0 0 2 52
USA und EU setzen auf lokale Impfstoffproduktion - Versorgungssicherheit im Fokus 0 0 0 3 0 1 2 26
What Clients Want: Choices between Lawyers' Offerings 0 0 0 13 1 4 7 57
What Clients want: Choices between Lawyers' Offerings 0 0 0 17 1 2 2 50
What clients want: Choices between lawyers' offerings 0 0 0 2 3 5 8 35
Total Working Papers 2 4 59 3,707 114 226 422 11,261
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on the Belgian Gas Hub 0 0 0 0 3 4 5 7
Ausbau der deutschen Grundbreitbandversorgung: Lehren aus der Vergangenheit mahnen zur Besonnenheit 0 0 1 4 0 2 8 24
Changes in Common Ownership of German Companies 0 2 2 53 5 8 10 184
Collusion Through Joint R&D: An Empirical Assessment 0 0 1 54 2 5 8 203
Common Ownership Patterns in the European Banking Sector—The Impact of the Financial Crisis1 1 1 1 2 2 3 5 7
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 1 1 1 6 9 9 9
Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis 0 0 0 0 1 2 2 5
Deutschland muss seine Digitalstrategie überdenken, um den Anschluss nicht zu verlieren: Editorial 0 0 0 3 1 2 6 34
Diversification, Common Ownership, and Strategic Incentives 0 0 0 18 1 1 1 53
EFFECTIVE EUROPEAN ANTITRUST: DOES EC MERGER POLICY GENERATE DETERRENCE? 0 0 0 3 1 3 3 54
EU Competition Policy Enforcement Supports Investment in the Energy Sectors 0 0 0 4 2 5 8 38
EU-Regionalbeihilfen haben positiven Einfluss auf Investitionen 0 0 0 2 1 1 2 14
EU-Wettbewerbspolitik fördert Investitionen in den Energiesektoren 0 0 0 2 0 2 2 32
Effective European Antitrust: Does EC Merger Policy Generate Deterrence? 0 0 0 4 1 1 2 27
Endogenous mergers and endogenous efficiency gains: The efficiency defence revisited 0 0 0 87 3 4 8 278
Europeanization of EU member-state competition policy: The commission's leadership role 0 0 1 14 0 0 3 75
Harte Restriktionen scheinen die wirksamste Maßnahme zu sein, um in einer Pandemie den Flugverkehr zu beschränken: Interview 0 0 0 0 0 1 1 1
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 33 1 3 3 125
Learning dynamics in research alliances: A panel data analysis 0 0 0 32 0 1 5 228
Let’s Not Stick Together: Anticipation of Cartel and Merger Control in The Netherlands 0 0 0 20 0 1 1 88
Mandanten von Anwälten wollen kein Stundenhonorar 0 0 0 1 1 1 1 36
Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert 0 0 0 2 0 2 3 10
Merger Failures 0 0 2 11 5 8 12 181
Nur harte Corona-Regeln wirken sich auf den Passagierflugverkehr zwischen Deutschland und Mallorca aus 0 0 0 1 2 3 3 7
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 0 0 2 3 44
Only Strict Coronavirus Regulations for Vacationers Affect Passenger Air Traffic between Germany and Mallorca 0 0 0 0 0 0 2 12
Paying by the Hour: The Least Appealing Option for Clients of Lawyers 0 0 0 0 0 1 1 44
R&D Spillovers through RJV Cooperation 0 0 0 0 1 6 7 8
R&D spillovers through RJV cooperation 0 0 0 4 1 5 8 31
SCREENING AND MERGER ACTIVITY 0 0 0 0 2 3 6 94
SYNCHRONISING DEREGULATION IN PRODUCT AND LABOUR MARKETS 0 0 0 7 2 2 5 48
Schepping en vernietiging van banen: De invloed van O&O-actieve bedrijven 0 0 0 0 0 2 2 30
Settle for Now but Block for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 1 1 49 3 5 9 193
The Deterrence Effects of US Merger Policy Instruments 0 0 1 19 4 8 11 129
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 1 2 2 2 6 8
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 3 3 4 7 31
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 0 1 4 4 4
The Pricing Structure of Legal Services: Do Lawyers Offer What Clients Want? 0 0 1 2 1 2 8 18
The political economy of mobile telecommunications liberalization: Evidence from the OECD countries 0 0 0 70 2 5 9 250
Transformational Strategies and Productivity Growth: A Transformational‐Activities Perspective on Stagnation in the New‐Normal Business Landscape 0 0 0 2 2 2 4 15
US-Vermögensverwalter gewinnen in Deutschland an Bedeutung: Interview 0 0 0 0 0 3 4 6
Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen 0 0 0 3 0 1 2 18
Wichtig ist es, die Innovationseffekte der vielen Übernahmen zu berücksichtigen: Interview 0 0 0 0 0 1 1 2
Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten 0 0 1 1 0 0 2 6
Total Journal Articles 1 5 14 513 62 130 212 2,711
2 registered items for which data could not be found


Statistics updated 2026-01-09